The overall goal of the Kao Laboratory is to understand aspects of cancer and normal tissue biology that will ultimately allow us develop and refine anticancer treatment. We have attacked this goal via interrelated approaches that have included: (i) novel assays to study the integrity of the blood:brain:barrier (BBB) as a determinant of malignant brain tumor treatment success (ii) investigating the biology of histone deacetylases in cancer and normal tissues, its role in development and cellular growth, and in the response to histone deacetylase inhibitors and other treatment modifiers, and (iii) developing novel vertebrate-based systems to investigate the relative effects of treatment on cancer cell viability as well as normal tissue development and function. We believe the understanding resulting from these investigations will enable us to optimize the "therapeutic ratio" --developing more effective yet less toxic treatment strategies
McQuade C1, Al Zaki A, Desai Y, Vido M, Sakhuja T, Cheng Z, Hickey RJ, Joh D, Park SJ, Kao G, Dorsey JF, Tsourkas A.: A Multifunctional Nanoplatform for Imaging, Radiotherapy, and the Prediction of Therapeutic Response.
Small. Sep 29 2014.
Dorsey JF1, Kao GD, MacArthur KM, Ju M, Steinmetz D, Wileyto EP, Simone CB 2nd, Hahn SM.
: Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer patients undergoing definitive radiation therapy: Pilot study results.
Cancer. Sep 19 2014.
Ju M, Kao GD, Steinmetz D, Chandrasekaran S, Keefe SM, Guzzo TJ, Christodouleas JP, Hahn SM, Dorsey JF.: Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: A case study. Cancer Biol Ther. 15(6): 683-7, Jun 2014.
Macarthur KM, Kao GD, Chandrasekaran S, Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM, Dorsey JF.: Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res. 74(8): 2152-9, Apr 2014.
MacArthur KM, Kao GD, Hahn SM, Christodouleas JP, Bekelman JE, Dorsey JF: Preliminary results of a telomerase-based circulating tumor cell assay in prostate cancer patients undergoing definitive radiotherapy. J Clin Oncol. 32(4), Feb 2014.
Al Zaki A, Joh D, Cheng Z, de Barros AL, Kao G, Dorsey J, Tsourkas A.: Gold-Loaded Polymeric Micelles for Computed Tomography-Guided Radiation Therapy Treatment and Radiosensitization. ACS nano 8(1): 104-12, Jan 2014.
Joh DY, Kao GD, Murty S, Stangl M, Sun L, Al Zaki A, Xu X, Hahn SM, Tsourkas A, Dorsey JF.: Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. Transl Oncol. 6(6): 722-31, Dec 2013.
Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, Kao GD, Tsourkas A, Dorsey JF.
: Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
PLoS One. 8(4), Apr 30 2013.
Chandrasekaran S, Hollander A, Xu X, Benci JL, Davis JJ, Dorsey JF, Kao G.: 18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns. ScientificWorldJournal. 2013, Apr 4 2013.
Kimple RJ, Kao GD: A 10-year analysis of american society for radiation oncology junior faculty career development awards. Int J Radiat Oncol Biol Phys. 85(4): 924-8, Mar 2013.
back to top
Last updated: 05/13/2015
The Trustees of the University of Pennsylvania